Jiangxi Province Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University, Nanchang, Jiangxi 330006, China.
School of Medicine, Nanchang University, Nanchang, Jiangxi 330006, China.
Int J Environ Res Public Health. 2018 Feb 23;15(2):382. doi: 10.3390/ijerph15020382.
Hypertension has become the leading cause of death worldwide; data on hypertension among Nanchang adults are sparse. The aim of this study was to investigate the prevalence and gender-specific influencing factors of hypertension in adults in Nanchang, China. A cross-sectional survey was conducted with a representative sample of 2722 Chinese residents aged 18 years and above between May and September 2016, with a response rate of 92.4% (2516/2722). A stratified cluster sampling method was adopted in this study. Data on prevalence and influencing factors were obtained from a standard questionnaire and physical measurements. Univariate and multivariate logistic regressions were performed to analyze the influencing factors. The age-standardized prevalence was 19.8% (18.2-21.3) (male: 19.5% (18.0-21.1); female, 20.01% (18.5-21.6)). Factors positively associated with hypertension prevalence were past smoking, diabetes mellitus (DM), and overweight and obesity in both genders. Abdominal obesity and family history of cardiovascular diseases (CVD) were risk factors only in males; sleeping time and consumption of fresh vegetables and fruits were related to the prevalence of hypertension only in females. These findings will form the baseline information for the development of more effective approaches to enhance current prevention and control management of hypertension.
高血压已成为全球首要致死原因;南昌成年人高血压相关数据较为匮乏。本研究旨在调查中国南昌成年人高血压的患病率及性别特异性影响因素。2016 年 5 月至 9 月期间,采用代表性的 2722 名 18 岁及以上中国居民的横断面调查,应答率为 92.4%(2516/2722)。本研究采用分层整群抽样方法。通过标准问卷和体格测量获取患病率及影响因素数据。采用单因素和多因素 logistic 回归分析影响因素。年龄标准化患病率为 19.8%(18.2-21.3)(男性:19.5%(18.0-21.1);女性,20.01%(18.5-21.6))。与高血压患病率呈正相关的因素在两性中均为既往吸烟、糖尿病(DM)和超重及肥胖。腹型肥胖和心血管疾病(CVD)家族史仅为男性的危险因素;睡眠时间和新鲜蔬菜及水果的摄入仅与女性高血压患病率相关。这些发现将为制定更有效的方法以加强当前高血压预防和控制管理提供基线信息。